2023 BSE实践指南:对比剂增强超声心动图

2023-11-15 英国超声心动图学会 Echo Res Pract 发表于上海

超声造影剂(UCAs)在临床心脏病学中具有良好的作用,对比剂增强超声心动图已经发展成为一项常规技术。本文主要针对安全有效地使用对比剂提供实践指导。

中文标题:

2023 BSE实践指南:对比剂增强超声心动图

英文标题:

Contrast echocardiography: a practical guideline from the British Society of Echocardiography

发布机构:

英国超声心动图学会

发布日期:

2023-11-15

简要介绍:

超声造影剂(UCAs)在临床心脏病学中具有良好的作用,对比剂增强超声心动图已经发展成为一项常规技术。本文主要针对安全有效地使用对比剂提供实践指导。
 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2023 BSE实践指南:对比剂增强超声心动图.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9ee171c003a4499c, title=2023 BSE实践指南:对比剂增强超声心动图, enTitle=Contrast echocardiography: a practical guideline from the British Society of Echocardiography, guiderFrom=Echo Res Pract, authorId=0, author=, summary=超声造影剂(UCAs)在临床心脏病学中具有良好的作用,对比剂增强超声心动图已经发展成为一项常规技术。本文主要针对安全有效地使用对比剂提供实践指导。, cover=https://img.medsci.cn/Random/hospital-staff-doctor-review-PTX6YZP.jpg, journalId=0, articlesId=null, associationId=1294, associationName=英国超声心动图学会, associationIntro=, copyright=0, guiderPublishedTime=Wed Nov 15 00:00:00 CST 2023, originalUrl=, linkOutUrl=, content=<div class="guideDetailsCont flex-row-between-start" style="color: #333333;"> <div class="detailsContRight" style="color: #222222;">超声造影剂(UCAs)在临床心脏病学中具有良好的作用,对比剂增强超声心动图已经发展成为一项常规技术。本文主要针对安全有效地使用对比剂提供实践指导。</div> </div> <div class="detailsQRWrapper" style="color: #333333;"> <div id="app_detail" class="detailsQR" title="https://m.medlive.cn/guide/1/30321">&nbsp;</div> </div>, tagList=[TagDto(tagId=1796, tagName=超声心动图), TagDto(tagId=3970, tagName=对比剂), TagDto(tagId=89049, tagName=超声造影剂)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=89049, articleKeyword=超声造影剂, articleKeywordNum=6, guiderKeywordId=89049, guiderKeyword=超声造影剂, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1213, appHits=21, showAppHits=0, pcHits=89, showPcHits=1190, likes=0, shares=3, comments=2, approvalStatus=1, publishedTime=Fri Nov 17 07:05:00 CST 2023, publishedTimeString=2023-11-15, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Thu Nov 16 10:07:26 CST 2023, updatedBy=8538692, updatedName=梅斯话题小助手, updatedTime=Sat Jan 06 17:19:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2023 BSE实践指南:对比剂增强超声心动图.pdf)])
2023 BSE实践指南:对比剂增强超声心动图.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2185840, encodeId=aec421858409b, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=3QcE5WicGMmY42DWGbOYf1Q&s=100&t=1556301203, createdBy=df765178243, createdName=juniper2019, createdTime=Sun Feb 04 15:54:07 CST 2024, time=2024-02-04, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2168967, encodeId=8a28216896e2f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Fri Nov 17 09:11:17 CST 2023, time=2023-11-17, status=1, ipAttribution=福建省)]
    2024-02-04 juniper2019 来自江西省

    不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2185840, encodeId=aec421858409b, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=3QcE5WicGMmY42DWGbOYf1Q&s=100&t=1556301203, createdBy=df765178243, createdName=juniper2019, createdTime=Sun Feb 04 15:54:07 CST 2024, time=2024-02-04, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2168967, encodeId=8a28216896e2f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Fri Nov 17 09:11:17 CST 2023, time=2023-11-17, status=1, ipAttribution=福建省)]
    2023-11-17 1dea4a7em68(暂无匿称) 来自福建省

    谢谢分享

    0

拓展阅读

GE医疗**超声造影剂示卓安(R)在中国上市

GE医疗中国今日宣布,该公司旗下首款超声造影剂示卓安®(Sonazoid ®)已通过中国国家药品监督管理局(NMPA)审批,在中国正式上市。作为新一代特异性超声造影剂,示卓安®(Sonazoid ®)由GE医疗挪威奥斯陆研发中心研制而成,主要针对肝内及肝外脏器及病变的显影,可应用于肝脏局灶性病变血管相和枯否相的超声成像,全程监控肿瘤,从而实现早期诊断、策略优化、精准治疗、疗效监测及随访,对于推动肝

2021 EACVI立场声明:聚乙二醇过敏患者的超声造影剂超敏反应

欧洲协会心血管影像协会(EACVI,European Association of Cardiovascular Imaging) · 2021-06-24